Andra AP-fonden’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Buy |
169,928
+100,406
| +144% | +$8.03M | 0.13% | 194 |
|
|
2025
Q4 | $6.63M | Buy |
69,522
+50,244
| +261% | +$4.93M | 0.08% | 254 |
|
|
2025
Q3 | $1.88M | Buy |
19,278
+18,900
| +5,000% | +$1.96M | 0.02% | 341 |
|
|
2025
Q2 | $40.6K | Buy |
+378
| New | +$38.2K | ﹤0.01% | 460 |
|
|
2024
Q4 | – | Sell |
-378
| Closed | -$31.7K | – | 393 |
|
|
2024
Q3 | $31.7K | Hold |
378
| – | – | ﹤0.01% | 423 |
|
|
2024
Q2 | $29.1K | Buy |
+378
| New | +$27.7K | ﹤0.01% | 412 |
|
|
2023
Q3 | – | Sell |
-137,578
| Closed | -$7.44M | – | 307 |
|
|
2023
Q2 | $7.44M | Buy |
137,578
+9,800
| +8% | +$512K | 0.19% | 232 |
|
|
2023
Q1 | $6.39M | Buy |
127,778
+16,378
| +15% | +$772K | 0.17% | 274 |
|
|
2022
Q4 | $5.15M | Sell |
111,400
-17,300
| -13% | -$749K | 0.16% | 301 |
|
|
2022
Q3 | $4.99M | Sell |
128,700
-48,200
| -27% | -$1.93M | 0.16% | 281 |
|
|
2022
Q2 | $6.59M | Buy |
+176,900
| New | +$7.2M | 0.19% | 226 |
|
|
2021
Q4 | $12.1M | Sell |
284,700
-33,700
| -11% | -$1.42M | 0.25% | 143 |
|
|
2021
Q3 | $13.8M | Buy |
318,400
+34,000
| +12% | +$1.5M | 0.28% | 69 |
|
|
2021
Q2 | $12.2M | Buy |
284,400
+119,100
| +72% | +$5.01M | 0.25% | 107 |
|
|
2021
Q1 | $6.39M | Sell |
165,300
-44,200
| -21% | -$1.67M | 0.14% | 361 |
|
|
2020
Q4 | $7.53M | Buy |
209,500
+123,200
| +143% | +$4.44M | 0.17% | 302 |
|
|
2020
Q3 | $3.3M | Sell |
86,300
-2,000
| -2% | -$77.1K | 0.09% | 496 |
|
|
2020
Q2 | $3.1M | Sell |
88,300
-42,400
| -32% | -$1.53M | 0.09% | 539 |
|
|
2020
Q1 | $4.26M | Buy |
130,700
+63,000
| +93% | +$2.46M | 0.16% | 299 |
|
|
2019
Q4 | $3.06M | Sell |
67,700
-53,400
| -44% | -$2.23M | 0.09% | 551 |
|
|
2019
Q3 | $4.93M | Sell |
121,100
-8,300
| -6% | -$352K | 0.15% | 359 |
|
|
2019
Q2 | $5.56M | Sell |
129,400
-15,700
| -11% | -$604K | 0.16% | 308 |
|
|
2019
Q1 | $5.57M | Buy |
+145,100
| New | +$5.54M | 0.16% | 302 |
|
|
2018
Q3 | $6.75M | Buy |
175,300
+47,200
| +37% | +$1.65M | 0.17% | 238 |
|
|
2018
Q2 | $4.19M | Sell |
128,100
-28,400
| -18% | -$857K | 0.11% | 461 |
|
|
2018
Q1 | $4.28M | Sell |
156,500
-73,500
| -32% | -$2M | 0.11% | 484 |
|
|
2017
Q4 | $5.7M | Buy |
230,000
+40,400
| +21% | +$1.11M | 0.13% | 219 |
|
|
2017
Q3 | $5.53M | Sell |
189,600
-21,700
| -10% | -$599K | 0.13% | 216 |
|
|
2017
Q2 | $5.86M | Buy |
211,300
+5,100
| +2% | +$135K | 0.15% | 189 |
|
|
2017
Q1 | $5.13K | Buy |
206,200
+1,300
| +0.6% | +$31.6K | 0.12% | 228 |
|
|
2016
Q4 | $4.43M | Buy |
204,900
+74,300
| +57% | +$1.62M | 0.12% | 261 |
|
|
2016
Q3 | $3.11M | Buy |
130,600
+11,200
| +9% | +$267K | 0.08% | 386 |
|
|
2016
Q2 | $2.79M | Buy |
119,400
+36,900
| +45% | +$798K | 0.07% | 437 |
|
|
2016
Q1 | $1.55M | Sell |
82,500
-5,600
| -6% | -$98.4K | 0.04% | 564 |
|
|
2015
Q4 | $1.63M | Sell |
88,100
-9,800
| -10% | -$176K | 0.05% | 508 |
|
|
2015
Q3 | $1.61M | Buy |
97,900
+20,900
| +27% | +$357K | 0.05% | 513 |
|
|
2015
Q2 | $1.36M | Sell |
77,000
-80,700
| -51% | -$1.44M | 0.04% | 533 |
|
|
2015
Q1 | $2.8M | Sell |
157,700
-195,000
| -55% | -$3.08M | 0.08% | 375 |
|
|
2014
Q4 | $4.67M | Sell |
352,700
-222,200
| -39% | -$2.84M | 0.11% | 290 |
|
|
2014
Q3 | $6.79M | Sell |
574,900
-49,900
| -8% | -$628K | 0.16% | 205 |
|
|
2014
Q2 | $7.98M | Buy |
624,800
+333,300
| +114% | +$4.33M | 0.17% | 189 |
|
|
2014
Q1 | $3.94M | Sell |
291,500
-10,400
| -3% | -$137K | 0.09% | 352 |
|
|
2013
Q4 | $3.63M | Buy |
301,900
+72,300
| +31% | +$854K | 0.09% | 348 |
|
|
2013
Q3 | $2.7M | Sell |
229,600
-32,400
| -12% | -$350K | 0.07% | 383 |
|
|
2013
Q2 | $2.43M | Buy |
+262,000
| New | +$2.22M | 0.06% | 395 |
|
Other funds holding BSX
VCM
VPM
Andra AP-fonden's BSX Position: Q1 2026 in Review
Andra AP-fonden increased its Boston Scientific (BSX) stake by 144% in Q1 2026, buying an estimated $8.03M and bringing the position to 169,928 shares worth $10.7M. The position accounts for 0.13% of the portfolio, ranked #194.
Andra AP-fonden first reported a position in BSX in Q2 2013 and has held it in 45 quarters since. The position peaked at $13.8M in Q3 2021. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Andra AP-fonden held 169,928 shares of Boston Scientific worth $10.7M as of Q1 2026.
- Andra AP-fonden bought 100,406 Boston Scientific shares in Q1 2026, an estimated $8.03M.
- Boston Scientific made up 0.13% of Andra AP-fonden's portfolio in Q1 2026, its #194 holding.
- Andra AP-fonden first reported a position in Boston Scientific in Q2 2013 and has held it in 45 quarters since.
- Andra AP-fonden's Boston Scientific position peaked at $13.8M in Q3 2021.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.